Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Varigard, LLC received an FDA Warning Letter on December 29, 2021, regarding drug products. Without access to the full warning letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter was issued under FDA's drug regulatory authority, but the issuing office and exact violation details remain unknown. To understand the specific compliance concerns, the complete warning letter would need to be reviewed.